At the root of this deterioration of physical fitness is damage to mitochondria, the cells powerhouse, and, ultimately, cells caused by oxidative stress the buildup of harmful, oxygen-containing molecules and lack of antioxidants
Armed with this genetic context, you and your provider can have a more informed discussion about whether standard-dose semaglutide, microdose GLP-1 protocols, tirzepatide, or dual-compound approaches (like GLP-Squared) may be worth exploring based on your individual risk profile and side effect tolerability
Health systems and clinicians should evaluate how these changes affect patient demand, prescribing patterns, and care coordination, while remaining alert to further guidance from CMS and the FDA as demonstration models unfold.
Varying the grace period between 60 and 365 days meant that the discontinuation rates at 3 years after treatment initiation ranged from 23% to 44% among GLP-1 receptor agonist users and from 29% to 51% among SGLT2 inhibitor users
Differences between groups were analyzed by Students t test or one-way analysis of variance (ANOVA) followed by Tukeys test
The semaglutide results showed a much higher lean share, raising alarms among experts
